SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sharon Bio-Medicine - Quaterly Results

17 May 2022 Evaluate
A minor change in the total revenue was seen in the March 2022 quarter. The total revenue for the quarter stood at Rs. 497.72 millions against Rs. 485.71 millions during year ago period.The Company's Net profit for the March 2022 quarter have declined marginally to Rs. 46.81  millions as against Rs. 56.10 millions reported during the corresponding quarter ended.The company reported a degrowth in operating Profit to 75.09 millions from 85.35 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 497.72 485.71 2.47 1883.91 1728.62 8.98 1883.91 1728.62 8.98
Other Income 11.26 20.77 -45.79 28.11 41.05 -31.52 28.11 41.05 -31.52
PBIDT 75.09 85.35 -12.02 290.14 257.33 12.75 290.14 257.33 12.75
Interest 0.24 0.39 -38.46 1.10 1.75 -37.14 1.10 1.75 -37.14
PBDT 74.85 84.96 -11.90 289.04 255.58 13.09 289.04 255.58 13.09
Depreciation 28.04 28.86 -2.84 112.29 115.12 -2.46 112.29 115.12 -2.46
PBT 46.81 56.10 -16.56 176.75 140.46 25.84 176.75 140.46 25.84
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 46.81 56.10 -16.56 176.75 140.46 25.84 176.75 140.46 25.84
Equity 11.51 11.51 0.00 11.51 11.51 0.00 11.51 11.51 0.00
PBIDTM(%) 15.09 17.57 -14.14 15.40 14.89 3.46 15.40 14.89 3.46
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×